News

Filter

Current filters:

None

7826 to 7835 of 96546 results

Israel'sTeva beats expectations with 40% leap in profit

09-05-2012

Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) has reported a robust set of first-quarter…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Exec appointments at Novo Nordisk and Teva

09-05-2012

Danish insulin giant Novo Nordisk (NOV: N) says that former Pfizer executive Robert Clark will be joining…

GenericsManagementNovo NordiskPharmaceuticalTeva Pharmaceutical Industries

Elelyso: a new therapeutic option for patients with Gaucher disease

09-05-2012

The US Food and Drug Administration recently approved Protalix BioTherapeutic's (NYSE-AMEX: OLX) Elelyso…

CerezymeElelysoGenzymeMarkets & MarketingPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesShireVpriv

Concerns over drug resistance in Gram-negative infections has led to changes in drug usage in USA

09-05-2012

Piperacillin-tazobactam is a leading and preferred therapy for Gram-negative infections (GNIs), accounting…

Antibiotics and Infectious diseasesMarkets & MarketingNorth AmericaPharmaceutical

GlaxoSmithKline goes on attack over Human Genome bid

09-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) went into attack mode this morning, taking its unsolicited…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMarkets & MarketingPharmaceutical

Santen to co-promote Bayer and Regeneron's Eylea in Japan

09-05-2012

German drug major Bayer's (BAYN: DE) Japanese subsidiary, Bayer Yakuhin, and Santen Pharmaceutical (TYO:…

Asia-PacificBayerEyleaLicensingMarkets & MarketingOphthalmicsPharmaceuticalRegeneronSanten Pharmaceuticals

7826 to 7835 of 96546 results

Back to top